EPISODE · Nov 14, 2006 · 5 MIN
The Lancet Neurology: November 14, 2006
from Listen to The Lancet Neurology · host The Lancet
December's Listen to The Lancet Neurology highlights the negative outcome of a trial of the drug TCH346 as a neuroprotective agent for Parkinson's disease, a Review about meningiomas, and depression among people with neurological disease.
NOW PLAYING
The Lancet Neurology: November 14, 2006
0:00
5:12
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Listen to The Lancet Neurology?
This episode is 5 minutes long.
When was this Listen to The Lancet Neurology episode published?
This episode was published on November 14, 2006.
What is this episode about?
December's Listen to The Lancet Neurology highlights the negative outcome of a trial of the drug TCH346 as a neuroprotective agent for Parkinson's disease, a Review about meningiomas, and depression among people with neurological disease.
Can I download this Listen to The Lancet Neurology episode?
Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!